Latest biopharmaceuticals Stories
- Novartis returns Alisporivir (DEB025) to Debiopharm Group(TM) including all rights for HCV and other indications - LAUSANNE, Switzerland, January 12, 2015 /PRNewswire/ --
Debio 1450, oral/IV FabI inhibitor active against all Staphylococcus species has received fast track designation for ABSSSI (acute bacterial skin and skin structure infections) LAUSANNE, Switzerland,
DALLAS, December 11, 2014 /PRNewswire/ -- RnRMarketResearch.com adds "Breast Cancer - Pipeline Review, H2 2014" and "Adrenocortical Carcinoma (Adrenal Cortex Cancer) -
The company leverages its keen understanding of protein purification to achieve the highest purification standards and product quality LONDON, Dec.
LAUSANNE, Switzerland, November 18, 2014 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs
Editor Note: For more information about this release, please scroll to bottom. LONDON, November 17, 2014 /PRNewswire/ -- Investor-Edge has initiated coverage on
BALTIMORE, Oct. 28, 2014 /PRNewswire/ -- Paragon Bioservices, Inc.
Editor Note: For more information about this release, please scroll to bottom. LONDON, October 14, 2014 /PRNewswire/ -- Investor-Edge has initiated coverage on
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.